
DL-Penicillamine
CAS No. 52-66-4
DL-Penicillamine ( —— )
产品货号. M14864 CAS No. 52-66-4
青霉素类抗生素最具特征性的降解产物。它被用作抗风湿药和威尔逊氏病的螯合剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥259 | 有现货 |
![]() ![]() |
25MG | ¥551 | 有现货 |
![]() ![]() |
50MG | ¥883 | 有现货 |
![]() ![]() |
100MG | ¥1158 | 有现货 |
![]() ![]() |
200MG | ¥1628 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称DL-Penicillamine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述青霉素类抗生素最具特征性的降解产物。它被用作抗风湿药和威尔逊氏病的螯合剂。
-
产品描述The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. (In Vivo):DL-Penicillamine (25 mg/kg; i.p.; twice daily, for 5 days) has antidotal effects in thallotoxicosis rats when co-treated with Prussian blue (HY-106594A).
-
体外实验——
-
体内实验DL-Penicillamine (25 mg/kg; i.p.; twice daily, for 5 days) has antidotal effects in thallotoxicosis rats when co-treated with Prussian blue (HY-106594A). Animal Model:Male Wistar rats, NIH strain (intoxicated by i.p. injection of 32 mg/kg thallium (I) acetate)Dosage:25 mg/kg Administration:i.p.; twice daily, for 5 daysResult:Decreased slightly the thallium content in blood, organs and brain.Increased the probability survival when co-treated with Prussian blue (50 mg/kg; p.o.).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number52-66-4
-
分子量149.21
-
分子式C5H11NO2S
-
纯度>98% (HPLC)
-
溶解度Free soluble in Water
-
SMILESCC(C)(S)C(N)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Brewer GJ. Expert Opin PharmacOthers. 2006, 7(3):317-24
产品手册




关联产品
-
Suavissimoside F1
Suavissimoside F1 is a natural product.
-
[pThr3]-CDK5 Substra...
[pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.
-
Cyclovirobuxin D
Cyclovirobuxine D (CVB-D) 是中药黄杨 Buxus microphylla 的主要活性成分。Cyclovirobuxine D 诱导自噬并减弱 Akt 和 mTOR 的磷酸化。Cyclovirobuxine D 通过抑制细胞周期进程和诱导线粒体介导的细胞凋亡 apoptosis 抑制癌细胞的增殖。Cyclovirobuxine D 有潜力用于心肌梗死引起的心力衰竭的研究。